hotspot -WSS

hotspot

author：fashion 2025-09-30 23:39:30 - browse：98

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — A newly approved Alzheimer’s drug made by Eisai and Biogen, called Leqembi, aims to clear out amyloid plaques in patients’ brains. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

WASHINGTON — Medicare on Monday proposed ending restrictions on how many PET scans patients can receive to detect amyloid plaques in their brains, which will offer physicians more options as they treat patients with a new drug to slow the progression of dementia.

The agency that oversees Medicare had previously restricted coverage to a single scan for patients who participated in clinical studies. Advocates had warned that could cause issues related to a new class of Alzheimer’s drugs designed to clear those plaques.

“We know there is significant interest in the medical community about new treatments that may be effective in slowing the development of Alzheimer’s disease. PET scans are an important part of diagnosis and treatment of Alzheimer’s disease,” Centers for Medicare and Medicaid Administrator Chiquita Brooks-LaSure said in a written statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Medicare drug price negotiation’s day in court

Wikipedia

WSS

Are infertility treatments 'essential' during the Covid

The lessons of Aduhelm, an Alzheimer's drug that was not to be

When a patient nears the end, a feared therapy can comfort

Congressmen charge Covid hearing ‘could have been an email’

Commercial surrogacy can be ethical, despite pope’s claims

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

hotspot

hotspot

leisure time

Novavax promises a turnaround & Lilly roils the obesity market

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Malaria cases in Florida and Texas: Here’s what you need to know

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Medical leaders decry Supreme Court decision on affirmative action

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Medicare details structure of new drug price negotiation program

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Medicare details structure of new drug price negotiation program

New Ultima Genomics DNA sequencer can read genome for $100

explore

Time to name cancers by genetics, not organ of origin, expert says

ARCH Venture Partners is raising $3 billion for a life sciences fund

Commercial surrogacy can be ethical, despite pope’s claims

5 dead in mass shooting on Caribbean island of St. Vincent: Police

After a decade, new Gardasil ad campaign gets it (mostly) right

Delta passengers in Vegas fall sick while waiting on flight in triple

Wikipedia

leisure time

entertainment

hotspot